 | • レポートコード：MRC2Q12-00900 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、アンフェプラモン（ジエチルプロピオン）APIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 アンフェプラモン（ジエチルプロピオン）APIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 アンフェプラモン（ジエチルプロピオン）APIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 アンフェプラモン（ジエチルプロピオン）APIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのアンフェプラモン（ジエチルプロピオン）APIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のアンフェプラモン（ジエチルプロピオン）APIの売上および2028年までの予測に焦点を当てています。 アンフェプラモン（ジエチルプロピオン）APIのグローバル主要企業には、Avantor、Sanofi、Pfizer、Arevipharma、Fiore、ACS Dobfar、Tiefenbacher Group、Varda Biotec、Toronto Research Chemicals、Radiant Pharma、Overlack、Jigs Chemical、Biosynt、Amfinecom、USVなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 アンフェプラモン（ジエチルプロピオン）API市場は、タイプとアプリケーションによって区分されます。世界のアンフェプラモン（ジエチルプロピオン）API市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 バレル、バッグ 【アプリケーション別セグメント】 食欲抑制剤、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - アンフェプラモン（ジエチルプロピオン）API製品概要 - タイプ別市場（バレル、バッグ） - アプリケーション別市場（食欲抑制剤、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のアンフェプラモン（ジエチルプロピオン）API販売量予測2017-2028 - 世界のアンフェプラモン（ジエチルプロピオン）API売上予測2017-2028 - アンフェプラモン（ジエチルプロピオン）APIの地域別販売量 - アンフェプラモン（ジエチルプロピオン）APIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別アンフェプラモン（ジエチルプロピオン）API販売量 - 主要メーカー別アンフェプラモン（ジエチルプロピオン）API売上 - 主要メーカー別アンフェプラモン（ジエチルプロピオン）API価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（バレル、バッグ） - アンフェプラモン（ジエチルプロピオン）APIのタイプ別販売量 - アンフェプラモン（ジエチルプロピオン）APIのタイプ別売上 - アンフェプラモン（ジエチルプロピオン）APIのタイプ別価格 ・アプリケーション別市場規模（食欲抑制剤、その他） - アンフェプラモン（ジエチルプロピオン）APIのアプリケーション別販売量 - アンフェプラモン（ジエチルプロピオン）APIのアプリケーション別売上 - アンフェプラモン（ジエチルプロピオン）APIのアプリケーション別価格 ・北米市場 - 北米のアンフェプラモン（ジエチルプロピオン）API市場規模（タイプ別、アプリケーション別） - 主要国別のアンフェプラモン（ジエチルプロピオン）API市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのアンフェプラモン（ジエチルプロピオン）API市場規模（タイプ別、アプリケーション別） - 主要国別のアンフェプラモン（ジエチルプロピオン）API市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のアンフェプラモン（ジエチルプロピオン）API市場規模（タイプ別、アプリケーション別） - 主要国別のアンフェプラモン（ジエチルプロピオン）API市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のアンフェプラモン（ジエチルプロピオン）API市場規模（タイプ別、アプリケーション別） - 主要国別のアンフェプラモン（ジエチルプロピオン）API市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのアンフェプラモン（ジエチルプロピオン）API市場規模（タイプ別、アプリケーション別） - 主要国別のアンフェプラモン（ジエチルプロピオン）API市場規模（トルコ、サウジアラビア） ・企業情報 Avantor、Sanofi、Pfizer、Arevipharma、Fiore、ACS Dobfar、Tiefenbacher Group、Varda Biotec、Toronto Research Chemicals、Radiant Pharma、Overlack、Jigs Chemical、Biosynt、Amfinecom、USV ・産業チェーン及び販売チャネル分析 - アンフェプラモン（ジエチルプロピオン）APIの産業チェーン分析 - アンフェプラモン（ジエチルプロピオン）APIの原材料 - アンフェプラモン（ジエチルプロピオン）APIの生産プロセス - アンフェプラモン（ジエチルプロピオン）APIの販売及びマーケティング - アンフェプラモン（ジエチルプロピオン）APIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - アンフェプラモン（ジエチルプロピオン）APIの産業動向 - アンフェプラモン（ジエチルプロピオン）APIのマーケットドライバー - アンフェプラモン（ジエチルプロピオン）APIの課題 - アンフェプラモン（ジエチルプロピオン）APIの阻害要因 ・主な調査結果 |
Amfepramone, also known as diethylpropion, is a stimulant drug of the phenethylamine, amphetamine, and cathinone classes that is used as an appetite suppressant
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Amfepramone(Diethylpropion) API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Amfepramone(Diethylpropion) API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Amfepramone(Diethylpropion) API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Amfepramone(Diethylpropion) API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Amfepramone(Diethylpropion) API include Avantor, Sanofi, Pfizer, Arevipharma, Fiore, ACS Dobfar, Tiefenbacher Group, Varda Biotec and Toronto Research Chemicals, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Amfepramone(Diethylpropion) API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Amfepramone(Diethylpropion) API by region (region level and country level), by company, by Wrap and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Amfepramone(Diethylpropion) API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Amfepramone(Diethylpropion) API market. Further, it explains the major drivers and regional dynamics of the global Amfepramone(Diethylpropion) API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Avantor
Sanofi
Pfizer
Arevipharma
Fiore
ACS Dobfar
Tiefenbacher Group
Varda Biotec
Toronto Research Chemicals
Radiant Pharma
Overlack
Jigs Chemical
Biosynt
Amfinecom
USV
Market Segments
This report has explored the key segments: by Wrap and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Amfepramone(Diethylpropion) API Segment by Wrap
Barreled
Bags
Amfepramone(Diethylpropion) API Segment by Application
Appetite Suppressant
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Amfepramone(Diethylpropion) API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Amfepramone(Diethylpropion) API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Amfepramone(Diethylpropion) API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Amfepramone(Diethylpropion) API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Amfepramone(Diethylpropion) API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Amfepramone(Diethylpropion) API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Amfepramone(Diethylpropion) API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Amfepramone(Diethylpropion) API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Avantor, Sanofi, Pfizer, Arevipharma, Fiore, ACS Dobfar, Tiefenbacher Group, Varda Biotec and Toronto Research Chemicals, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Amfepramone(Diethylpropion) API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Amfepramone(Diethylpropion) API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Amfepramone(Diethylpropion) API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by wrap, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by wrap, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by wrap, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by wrap, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by wrap, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amfepramone(Diethylpropion) API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Amfepramone(Diethylpropion) API Product Introduction
1.2 Market by Wrap
1.2.1 Global Amfepramone(Diethylpropion) API Market Size by Wrap, 2017 VS 2021 VS 2028
1.2.2 Barreled
1.2.3 Bags
1.3 Market by Application
1.3.1 Global Amfepramone(Diethylpropion) API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Appetite Suppressant
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Amfepramone(Diethylpropion) API Production
2.1 Global Amfepramone(Diethylpropion) API Production Capacity (2017-2028)
2.2 Global Amfepramone(Diethylpropion) API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Amfepramone(Diethylpropion) API Production by Region
2.3.1 Global Amfepramone(Diethylpropion) API Historic Production by Region (2017-2022)
2.3.2 Global Amfepramone(Diethylpropion) API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Amfepramone(Diethylpropion) API Sales in Volume & Value Estimates and Forecasts
3.1 Global Amfepramone(Diethylpropion) API Sales Estimates and Forecasts 2017-2028
3.2 Global Amfepramone(Diethylpropion) API Revenue Estimates and Forecasts 2017-2028
3.3 Global Amfepramone(Diethylpropion) API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Amfepramone(Diethylpropion) API Sales by Region
3.4.1 Global Amfepramone(Diethylpropion) API Sales by Region (2017-2022)
3.4.2 Global Sales Amfepramone(Diethylpropion) API by Region (2023-2028)
3.5 Global Amfepramone(Diethylpropion) API Revenue by Region
3.5.1 Global Amfepramone(Diethylpropion) API Revenue by Region (2017-2022)
3.5.2 Global Amfepramone(Diethylpropion) API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Amfepramone(Diethylpropion) API Production Capacity by Manufacturers
4.2 Global Amfepramone(Diethylpropion) API Sales by Manufacturers
4.2.1 Global Amfepramone(Diethylpropion) API Sales by Manufacturers (2017-2022)
4.2.2 Global Amfepramone(Diethylpropion) API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Amfepramone(Diethylpropion) API in 2021
4.3 Global Amfepramone(Diethylpropion) API Revenue by Manufacturers
4.3.1 Global Amfepramone(Diethylpropion) API Revenue by Manufacturers (2017-2022)
4.3.2 Global Amfepramone(Diethylpropion) API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Amfepramone(Diethylpropion) API Revenue in 2021
4.4 Global Amfepramone(Diethylpropion) API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Amfepramone(Diethylpropion) API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Amfepramone(Diethylpropion) API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Wrap
5.1 Global Amfepramone(Diethylpropion) API Sales by Wrap
5.1.1 Global Amfepramone(Diethylpropion) API Historical Sales by Wrap (2017-2022)
5.1.2 Global Amfepramone(Diethylpropion) API Forecasted Sales by Wrap (2023-2028)
5.1.3 Global Amfepramone(Diethylpropion) API Sales Market Share by Wrap (2017-2028)
5.2 Global Amfepramone(Diethylpropion) API Revenue by Wrap
5.2.1 Global Amfepramone(Diethylpropion) API Historical Revenue by Wrap (2017-2022)
5.2.2 Global Amfepramone(Diethylpropion) API Forecasted Revenue by Wrap (2023-2028)
5.2.3 Global Amfepramone(Diethylpropion) API Revenue Market Share by Wrap (2017-2028)
5.3 Global Amfepramone(Diethylpropion) API Price by Wrap
5.3.1 Global Amfepramone(Diethylpropion) API Price by Wrap (2017-2022)
5.3.2 Global Amfepramone(Diethylpropion) API Price Forecast by Wrap (2023-2028)
6 Market Size by Application
6.1 Global Amfepramone(Diethylpropion) API Sales by Application
6.1.1 Global Amfepramone(Diethylpropion) API Historical Sales by Application (2017-2022)
6.1.2 Global Amfepramone(Diethylpropion) API Forecasted Sales by Application (2023-2028)
6.1.3 Global Amfepramone(Diethylpropion) API Sales Market Share by Application (2017-2028)
6.2 Global Amfepramone(Diethylpropion) API Revenue by Application
6.2.1 Global Amfepramone(Diethylpropion) API Historical Revenue by Application (2017-2022)
6.2.2 Global Amfepramone(Diethylpropion) API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Amfepramone(Diethylpropion) API Revenue Market Share by Application (2017-2028)
6.3 Global Amfepramone(Diethylpropion) API Price by Application
6.3.1 Global Amfepramone(Diethylpropion) API Price by Application (2017-2022)
6.3.2 Global Amfepramone(Diethylpropion) API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Amfepramone(Diethylpropion) API Market Size by Wrap
7.1.1 North America Amfepramone(Diethylpropion) API Sales by Wrap (2017-2028)
7.1.2 North America Amfepramone(Diethylpropion) API Revenue by Wrap (2017-2028)
7.2 North America Amfepramone(Diethylpropion) API Market Size by Application
7.2.1 North America Amfepramone(Diethylpropion) API Sales by Application (2017-2028)
7.2.2 North America Amfepramone(Diethylpropion) API Revenue by Application (2017-2028)
7.3 North America Amfepramone(Diethylpropion) API Sales by Country
7.3.1 North America Amfepramone(Diethylpropion) API Sales by Country (2017-2028)
7.3.2 North America Amfepramone(Diethylpropion) API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Amfepramone(Diethylpropion) API Market Size by Wrap
8.1.1 Europe Amfepramone(Diethylpropion) API Sales by Wrap (2017-2028)
8.1.2 Europe Amfepramone(Diethylpropion) API Revenue by Wrap (2017-2028)
8.2 Europe Amfepramone(Diethylpropion) API Market Size by Application
8.2.1 Europe Amfepramone(Diethylpropion) API Sales by Application (2017-2028)
8.2.2 Europe Amfepramone(Diethylpropion) API Revenue by Application (2017-2028)
8.3 Europe Amfepramone(Diethylpropion) API Sales by Country
8.3.1 Europe Amfepramone(Diethylpropion) API Sales by Country (2017-2028)
8.3.2 Europe Amfepramone(Diethylpropion) API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Amfepramone(Diethylpropion) API Market Size by Wrap
9.1.1 Asia Pacific Amfepramone(Diethylpropion) API Sales by Wrap (2017-2028)
9.1.2 Asia Pacific Amfepramone(Diethylpropion) API Revenue by Wrap (2017-2028)
9.2 Asia Pacific Amfepramone(Diethylpropion) API Market Size by Application
9.2.1 Asia Pacific Amfepramone(Diethylpropion) API Sales by Application (2017-2028)
9.2.2 Asia Pacific Amfepramone(Diethylpropion) API Revenue by Application (2017-2028)
9.3 Asia Pacific Amfepramone(Diethylpropion) API Sales by Region
9.3.1 Asia Pacific Amfepramone(Diethylpropion) API Sales by Region (2017-2028)
9.3.2 Asia Pacific Amfepramone(Diethylpropion) API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Amfepramone(Diethylpropion) API Market Size by Wrap
10.1.1 Latin America Amfepramone(Diethylpropion) API Sales by Wrap (2017-2028)
10.1.2 Latin America Amfepramone(Diethylpropion) API Revenue by Wrap (2017-2028)
10.2 Latin America Amfepramone(Diethylpropion) API Market Size by Application
10.2.1 Latin America Amfepramone(Diethylpropion) API Sales by Application (2017-2028)
10.2.2 Latin America Amfepramone(Diethylpropion) API Revenue by Application (2017-2028)
10.3 Latin America Amfepramone(Diethylpropion) API Sales by Country
10.3.1 Latin America Amfepramone(Diethylpropion) API Sales by Country (2017-2028)
10.3.2 Latin America Amfepramone(Diethylpropion) API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Amfepramone(Diethylpropion) API Market Size by Wrap
11.1.1 Middle East and Africa Amfepramone(Diethylpropion) API Sales by Wrap (2017-2028)
11.1.2 Middle East and Africa Amfepramone(Diethylpropion) API Revenue by Wrap (2017-2028)
11.2 Middle East and Africa Amfepramone(Diethylpropion) API Market Size by Application
11.2.1 Middle East and Africa Amfepramone(Diethylpropion) API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Amfepramone(Diethylpropion) API Revenue by Application (2017-2028)
11.3 Middle East and Africa Amfepramone(Diethylpropion) API Sales by Country
11.3.1 Middle East and Africa Amfepramone(Diethylpropion) API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Amfepramone(Diethylpropion) API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Avantor
12.1.1 Avantor Corporation Information
12.1.2 Avantor Overview
12.1.3 Avantor Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Avantor Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Avantor Recent Developments
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Overview
12.2.3 Sanofi Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Sanofi Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Sanofi Recent Developments
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Overview
12.3.3 Pfizer Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Pfizer Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Pfizer Recent Developments
12.4 Arevipharma
12.4.1 Arevipharma Corporation Information
12.4.2 Arevipharma Overview
12.4.3 Arevipharma Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Arevipharma Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Arevipharma Recent Developments
12.5 Fiore
12.5.1 Fiore Corporation Information
12.5.2 Fiore Overview
12.5.3 Fiore Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Fiore Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Fiore Recent Developments
12.6 ACS Dobfar
12.6.1 ACS Dobfar Corporation Information
12.6.2 ACS Dobfar Overview
12.6.3 ACS Dobfar Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 ACS Dobfar Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 ACS Dobfar Recent Developments
12.7 Tiefenbacher Group
12.7.1 Tiefenbacher Group Corporation Information
12.7.2 Tiefenbacher Group Overview
12.7.3 Tiefenbacher Group Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Tiefenbacher Group Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Tiefenbacher Group Recent Developments
12.8 Varda Biotec
12.8.1 Varda Biotec Corporation Information
12.8.2 Varda Biotec Overview
12.8.3 Varda Biotec Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Varda Biotec Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Varda Biotec Recent Developments
12.9 Toronto Research Chemicals
12.9.1 Toronto Research Chemicals Corporation Information
12.9.2 Toronto Research Chemicals Overview
12.9.3 Toronto Research Chemicals Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Toronto Research Chemicals Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Toronto Research Chemicals Recent Developments
12.10 Radiant Pharma
12.10.1 Radiant Pharma Corporation Information
12.10.2 Radiant Pharma Overview
12.10.3 Radiant Pharma Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Radiant Pharma Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Radiant Pharma Recent Developments
12.11 Overlack
12.11.1 Overlack Corporation Information
12.11.2 Overlack Overview
12.11.3 Overlack Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Overlack Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Overlack Recent Developments
12.12 Jigs Chemical
12.12.1 Jigs Chemical Corporation Information
12.12.2 Jigs Chemical Overview
12.12.3 Jigs Chemical Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Jigs Chemical Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Jigs Chemical Recent Developments
12.13 Biosynt
12.13.1 Biosynt Corporation Information
12.13.2 Biosynt Overview
12.13.3 Biosynt Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Biosynt Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Biosynt Recent Developments
12.14 Amfinecom
12.14.1 Amfinecom Corporation Information
12.14.2 Amfinecom Overview
12.14.3 Amfinecom Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Amfinecom Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Amfinecom Recent Developments
12.15 USV
12.15.1 USV Corporation Information
12.15.2 USV Overview
12.15.3 USV Amfepramone(Diethylpropion) API Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 USV Amfepramone(Diethylpropion) API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 USV Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Amfepramone(Diethylpropion) API Industry Chain Analysis
13.2 Amfepramone(Diethylpropion) API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Amfepramone(Diethylpropion) API Production Mode & Process
13.4 Amfepramone(Diethylpropion) API Sales and Marketing
13.4.1 Amfepramone(Diethylpropion) API Sales Channels
13.4.2 Amfepramone(Diethylpropion) API Distributors
13.5 Amfepramone(Diethylpropion) API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Amfepramone(Diethylpropion) API Industry Trends
14.2 Amfepramone(Diethylpropion) API Market Drivers
14.3 Amfepramone(Diethylpropion) API Market Challenges
14.4 Amfepramone(Diethylpropion) API Market Restraints
15 Key Finding in The Global Amfepramone(Diethylpropion) API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer